English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: This research aimed to develop sensitive, simple, and selective methods for determination of esomeprazole in human plasma using lansoprazole as internal standard by high performance liquid chromatography. Method: The analytical separation was performed on C-18 column (Waters, Sunfire™ 5 μm; 250 x 4.6 mm), column temperature 40°C. The mobile phase used acetonitrile - phosphate buffer pH 7.6 (40: 60% v/v) with a flow rate of 1.00 mL/min; and photodiode array detector at a wavelength of 300 nm. Esomeprazole and lansoprazole were extracted by liquid-liquid extraction using dichloromethane. Results: The method had a chromatographic run time of 10 min and linear calibration curve over the range of 5.0-450 ng/mL with a correlation coefficient (r) of 0.999 or better. The sensitivity, specificity, linearity, precision and accuracy, recovery and stability were validated for esomeprazole in human plasma. Conclusion: The results of validation fulfilled the acceptance criteria of validation method based on EMEA Bioanalytical Guideline 2011. Key words: Esomeprazole, HPLC, Optimization, Validation, Plasma.

Method Validation of Esomeprazole Analysis in Human Plasma using High Performance Liquid Chromatography–Photodiode Array